NCT01662518

DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

A Safety and Efficacy Study to Assess DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO)

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Centro de Pesquisa Rubens Siqueira · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone (DDS-25) for the treatment of macular edema associated with retinal vein occlusion.

Detailed description

Evaluate the effects on visual acuity, electroretinography, fluorescein angiography and optical coherence tomography in 10 patients with macular edema associated with retinal vein occlusion undergoing intravitreal injection of implant of dexamethasone (DDS-25).

Conditions

• Macular Edema
• Retinal Vein Occlusion

Interventions

Type	Name	Description
DEVICE	Dexamethasone drug delivery system (DDS-25)	350 mg Dexamethasone posterior segment drug delivery system (DDS-25) injection into the vitreous cavity at baseline

Timeline

• Start date: 2011-07-01
• Primary completion: 2016-01-01
• Completion: 2016-06-01
• First posted: 2012-08-10
• Last updated: 2017-02-01

Locations

1 site across 1 country: Brazil